To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
A recent study published in Scientific Reports correlates higher levels of pollutant particulate matter to higher occurrences of head and neck aerodigestive cancer. The article “ Air Pollution Exposure and Head and Neck Cancer Incidence ” is the work of a multi-institutional collaboration with researchers from Karmanos Cancer Institute, Wayne State University, Johns Hopkins University and Mass General Brigham. The study was led by John Cramer, M.D. , otolaryngologist, member of the Head and Ne...
The Office of Faculty Affairs and Professional Development at Wayne State University’s (WSU) School of Medicine annually recognizes faculty who have made outstanding contributions in teaching, mentoring, research, and leadership. This year, several Barbara Ann Karmanos Cancer Institute faculty, researchers, and medical staff at the Karmanos Cancer Center received these awards, highlighting their significant contributions to education and more. Others received promotions and tenure at Wayne State. School...
As it’s known that lung cancer can be a secondary cancer following a head and neck cancer, multiple oncologists and researchers at Karmanos contributed to a study that takes a look at the risk level among African American patients compared to White patients. Their study titled, “African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer,” will be published in Head & Neck. The contributing Karmanos specialists and researchers are: Am...